Patent holdings for IPC class A61K 39/00

Total number of patents in this class: 49690

10-year publication summary

2829
3301
3714
3645
3494
3661
3146
2637
4678
3482
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Immatics Biotechnologies GmbH
1153
889
Regeneron Pharmaceuticals, Inc.
4355
579
The Regents of the University of California
20108
577
The Trustees of the University of Pennsylvania
4349
511
Glaxosmithkline Biologicals S.A.
1651
492
Genentech, Inc.
4009
478
The United States of America, as represented by the Secretary, Department of Health and Human Services
2874
474
Novartis AG
10721
439
Janssen Biotech, Inc.
1561
321
Amgen Inc.
4108
318
The Board of Trustees of the Leland Stanford Junior University
6476
314
Memorial Sloan-Kettering Cancer Center
1955
309
Hoffmann-La Roche Inc.
3478
287
Board of Regents, The University of Texas System
5869
279
Bristol-myers Squibb Company
4849
266
Inserm (institut National de La Sante et de La Recherche Medicale)
3367
265
Pfizer Inc.
3386
249
Dana-Farber Cancer Institute, Inc.
2596
249
The General Hospital Corporation
4770
210
The Johns Hopkins University
5714
203
Other owners 41981